Literature DB >> 22922259

Expansion of HIV-specific T follicular helper cells in chronic HIV infection.

Madelene Lindqvist1, Jan van Lunzen, Damien Z Soghoian, Bjorn D Kuhl, Srinika Ranasinghe, Gregory Kranias, Michael D Flanders, Samuel Cutler, Naomi Yudanin, Matthias I Muller, Isaiah Davis, Donna Farber, Philip Hartjen, Friedrich Haag, Galit Alter, Julian Schulze zur Wiesch, Hendrik Streeck.   

Abstract

HIV targets CD4 T cells, which are required for the induction of high-affinity antibody responses and the formation of long-lived B cell memory. The depletion of antigen-specific CD4 T cells during HIV infection is therefore believed to impede the development of protective B cell immunity. Although several different HIV-related B cell dysfunctions have been described, the role of CD4 T follicular helper (TFH) cells in HIV infection remains unknown. Here, we assessed HIV-specific TFH responses in the lymph nodes of treatment-naive and antiretroviral-treated HIV-infected individuals. Strikingly, both the bulk TFH and HIV-specific TFH cell populations were significantly expanded in chronic HIV infection and were highly associated with viremia. In particular, GAG-specific TFH cells were detected at significantly higher levels in the lymph nodes compared with those of GP120-specific TFH cells and showed preferential secretion of the helper cytokine IL-21. In addition, TFH cell expansion was associated with an increase of germinal center B cells and plasma cells as well as IgG1 hypersecretion. Thus, our study suggests that high levels of HIV viremia drive the expansion of TFH cells, which in turn leads to perturbations of B cell differentiation, resulting in dysregulated antibody production.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922259      PMCID: PMC3428098          DOI: 10.1172/JCI64314

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1.

Authors:  Marie Pancera; Jason S McLellan; Xueling Wu; Jiang Zhu; Anita Changela; Stephen D Schmidt; Yongping Yang; Tongqing Zhou; Sanjay Phogat; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration.

Authors:  Stefan Kuchen; Rachel Robbins; Gary P Sims; Chen Sheng; Terence M Phillips; Peter E Lipsky; Rachel Ettinger
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

3.  HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function.

Authors:  Mathieu F Chevalier; Boris Jülg; Augustine Pyo; Michael Flanders; Srinika Ranasinghe; Damien Z Soghoian; Douglas S Kwon; Jenna Rychert; Jeffrey Lian; Matthias I Muller; Sam Cutler; Elizabeth McAndrew; Heiko Jessen; Florencia Pereyra; Eric S Rosenberg; Marcus Altfeld; Bruce D Walker; Hendrik Streeck
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

4.  Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7.

Authors:  Angela Malaspina; Susan Moir; Doreen G Chaitt; Catherine A Rehm; Shyam Kottilil; Judith Falloon; Anthony S Fauci
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

5.  IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

Authors:  Rachel Ettinger; Gary P Sims; Anna-Marie Fairhurst; Rachel Robbins; Yong Sing da Silva; Rosanne Spolski; Warren J Leonard; Peter E Lipsky
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

6.  Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.

Authors:  Mikulas Popovic; Klara Tenner-Racz; Colleen Pelser; Hans-Jurgen Stellbrink; Jan van Lunzen; George Lewis; Vaniambadi S Kalyanaraman; Robert C Gallo; Paul Racz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells.

Authors:  Xugang Qiao; Bing He; April Chiu; Daniel M Knowles; Amy Chadburn; Andrea Cerutti
Journal:  Nat Immunol       Date:  2006-01-22       Impact factor: 25.606

8.  Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.

Authors:  Kehmia Titanji; Francesca Chiodi; Rino Bellocco; Danika Schepis; Lyda Osorio; Chiara Tassandin; Giuseppe Tambussi; Sven Grutzmeier; Lucia Lopalco; Angelo De Milito
Journal:  AIDS       Date:  2005-11-18       Impact factor: 4.177

9.  Mucosal immunity to HIV: a review of recent literature.

Authors:  Barbara L Shacklett
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  251 in total

1.  Rapid HIV Progression Is Associated with Extensive Ongoing Somatic Hypermutation.

Authors:  Ben S Wendel; Yajing Fu; Chenfeng He; Stefany M Hernandez; Mingjuan Qu; Zining Zhang; Yongjun Jiang; Xiaoxu Han; Junjie Xu; Haibo Ding; Ning Jiang; Hong Shang
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

2.  Decreased T Follicular Regulatory Cell/T Follicular Helper Cell (TFH) in Simian Immunodeficiency Virus-Infected Rhesus Macaques May Contribute to Accumulation of TFH in Chronic Infection.

Authors:  Ankita Chowdhury; Perla Mariana Del Rio Estrada; Perla Maria Estrada Del Rio; Greg K Tharp; Ronald P Trible; Rama R Amara; Ann Chahroudi; Gustavo Reyes-Teran; Steven E Bosinger; Guido Silvestri
Journal:  J Immunol       Date:  2015-08-21       Impact factor: 5.422

Review 3.  CD4 T-cell immunotherapy for chronic viral infections and cancer.

Authors:  Alice O Kamphorst; Rafi Ahmed
Journal:  Immunotherapy       Date:  2013-09       Impact factor: 4.196

4.  Cell-intrinsic IL-27 and gp130 cytokine receptor signaling regulates virus-specific CD4⁺ T cell responses and viral control during chronic infection.

Authors:  James A Harker; Aleksandr Dolgoter; Elina I Zuniga
Journal:  Immunity       Date:  2013-08-29       Impact factor: 31.745

5.  HIV-1 single-stranded RNA induces CXCL13 secretion in human monocytes via TLR7 activation and plasmacytoid dendritic cell-derived type I IFN.

Authors:  Kristen W Cohen; Anne-Sophie Dugast; Galit Alter; M Juliana McElrath; Leonidas Stamatatos
Journal:  J Immunol       Date:  2015-02-09       Impact factor: 5.422

6.  Simian immunodeficiency virus confounds T follicular helper T cells and the germinal centre.

Authors:  Tom N Lea-Henry; Simon H Jiang
Journal:  Ann Transl Med       Date:  2016-12

Review 7.  Harnessing CD4⁺ T cell responses in HIV vaccine development.

Authors:  Hendrik Streeck; M Patricia D'Souza; Dan R Littman; Shane Crotty
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

Review 8.  Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?

Authors:  Jennifer Totonchy; Ethel Cesarman
Journal:  Curr Opin Virol       Date:  2016-09-23       Impact factor: 7.090

9.  Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques.

Authors:  Yin Xu; Chris Weatherall; Michelle Bailey; Sheilajen Alcantara; Robert De Rose; Jerome Estaquier; Kim Wilson; Kazuo Suzuki; Jacques Corbeil; David A Cooper; Stephen J Kent; Anthony D Kelleher; John Zaunders
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

Review 10.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.